The relation between inflammation and neurodegeneration in multiple sclerosis brains.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneNew and emerging disease modifying therapies for multiple sclerosisTreatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosisInterferon beta for secondary progressive multiple sclerosisInterferon beta for secondary progressive multiple sclerosisExpression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosisExploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosisThe Ins and Outs of B Cells in Multiple SclerosisHypersensitivity Responses in the Central Nervous SystemNovel Insights and Therapeutics in Multiple SclerosisBrain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?Neural Plasticity in Multiple Sclerosis: The Functional and Molecular BackgroundMultiple sclerosis-a quiet revolutionNutrition facts in multiple sclerosisOxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsStage-specific immune dysregulation in multiple sclerosisClinical correlates of grey matter pathology in multiple sclerosisPharmacological Approaches to Delaying Disability Progression in Patients with Multiple SclerosisAn update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerationsRole of CD8 T cell subsets in the pathogenesis of multiple sclerosisMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesTracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammationInterferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory DiseaseThe Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisImaging neuroinflammation in multiple sclerosis using TSPO-PETMultiple Sclerosis and T Lymphocytes: An Entangled StoryImaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple SclerosisAutoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?Pathology of multiple sclerosis: where do we stand?Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosisReprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytesDouble-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple SclerosisOligodendrocytes: biology and pathologyTreatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles.Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.
P2860
Q21558407-6428EFAC-42E4-4060-8F76-8DCEAC0F24B0Q22242305-8FC50924-9EEF-40CA-B2CB-9086BABC054DQ24185806-09645CA9-FB12-4045-8207-2F1AA6F36F63Q24203879-DBD89D8D-3FC6-4DC5-8E46-AD1A9D8FCFFEQ24240509-14111892-FFC4-4372-A9AD-CD7B00C1DDA0Q24603606-E0C05EC5-BC61-4989-80CE-0CC90C6B572AQ26770818-B9DEE652-09D9-4816-B82D-51D181A2DD60Q26776542-EC1D590D-3689-4D39-8902-0ACA8A4EB17FQ26779177-D0F16D66-B3A0-48BB-9577-72D31899530BQ26784619-6331EC71-D8A7-4567-8EE5-1751EE83332EQ26799233-06B86F38-F07B-4895-B47B-F62CD89A3CA6Q26801046-0CD8FB8E-BF82-4DCD-A7A9-A4FCCF9B47D3Q26826930-3E9F42F4-AC8A-4EB8-B88B-3F644B6D8BEAQ26851247-49E5542E-05AB-4EDB-86F1-DAB94436AD2BQ26851676-FE872BA3-7A64-408C-9D2C-124F743EEC6EQ26852859-AB5FDBE2-0DD2-4127-87A1-D77B553F6A26Q26999302-DF3FA9A0-5E15-405C-86B2-ACD942015301Q27000269-C81AE588-6930-4475-9CCE-47E0BC621489Q27009769-78FFE186-C87A-4469-A0BC-506973B10C17Q27010613-F3D42ECF-CDD4-409F-8C5D-0E911936DD86Q27023735-88002F24-42E7-4B1E-855C-6953E72C1DC3Q27322415-2B1201A1-61A9-4BC8-9E63-5243FC16A027Q27928023-6309FB32-7C1D-49F2-AC05-F765BBBC44EFQ28073377-013BF94C-F142-43DB-8127-DE5FC215F99EQ28078621-204A699E-F92E-4E40-80FA-DE09060C1844Q28080754-A3BF4CF8-5BDF-429A-9FDB-5EE30D5B1241Q28084625-FFA0FAD4-DED6-4793-A4DE-E832C8456D59Q28086853-4ED3C111-36BF-40D1-9857-062220945D36Q28267527-A5EF7778-76FE-412B-8369-1230E0E1500EQ28270642-DBC8EA5A-40DC-4CD1-B0AD-1A892E981288Q28296052-E215D55E-ECF7-4E05-8085-AE89F1384393Q28535303-D1EE33B8-1F41-4FA4-BD5A-34C0DC830A59Q28544716-CB9B164D-21CC-4B16-9E16-2DCEDAACC9F9Q28584487-715DDAD7-499A-41C2-9B40-5E2EEB13EE36Q30051584-5EC33AB6-DE6D-4079-925A-F02002A2914BQ30234672-F85D3F25-9422-4CCB-9EBE-292569734BC9Q30368046-56F15F1E-29FF-437C-9460-92191783F328Q30479247-BB2CDD0C-4514-4D3C-BBDD-4C1668F7B366Q30501593-FFFE8029-7ED1-4759-A5CF-8411112303CFQ30525646-ED5DAE14-23D8-4EEE-B83B-2DABFCF28A7A
P2860
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
@en
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
@nl
type
label
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
@en
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
@nl
prefLabel
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
@en
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
@nl
P2093
P2860
P50
P356
P1433
P1476
The relation between inflammation and neurodegeneration in multiple sclerosis brains
@en
P2093
Assunta Dal-Bianco
Claudia F Lucchinetti
Helmut Rauschka
Henning Laursen
Manfred Schmidbauer
Stephan Bramow
P2860
P304
P356
10.1093/BRAIN/AWP070
P407
P577
2009-03-31T00:00:00Z